Hypertensive urgency or high blood pressure variability?

doi:https://doi.org/10.17116/terarkh2017893108-111

Close metadata

Recommended articles:

Efficacy and tolerability of azilsartan combined with amlodipine and amlodipine monotherapy and combinations of amlodipine with other angiotensin II receptor blockers. Russian Cardiology Bulletin. 2024;(4-2):161-171

Risk factors and adverse outcomes of cardiovascular diseases in people with high normal blood pressure of the Ryazan region. (5-year prospective follow-up). Russian Journal of Preventive Medicine. 2025;(2):31-37

Diagnostics of hypertensive disorders in cardio-obstetrics: current state-of-affairs. Russian Journal of Human Reproduction. 2025;(1):63-77

Study of the levocarnitine efficacy for the treatment of moderate cognitive impairment in patients with hypertension. Russian Journal of Preventive Medicine. 2025;(4):45-50

Visceral obesity is a reversible factor in pathogenesis of major cardiovascular diseases. Russian Cardiology Bulletin. 2025;(3):11-16

Features of the interpretation of bodily sensations by patients with arterial hypertension. Russian Journal of Preventive Medicine. 2025;(10):82-87

Study of the effectiveness of the drug Elcarnitine in the correction of increased variability of arterial pressure in patients with hypertensive disease and cognitive dysfunction. Russian Journal of Preventive Medicine. 2025;(10):88-92

Features of arterial hypertension in individuals with anxiety disorders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(11):44-51

Abstract:

Hypertensive urgency (HU) is a common reason particularly for elderly patients to seek medical advice. Severe asymptomatic hypertension and situational high blood pressure (BP) in patients with its high variability is frequently taken as HU. The use of short-acting antihypertensive drugs is not only indicated in these situations, but it may also increase the risk of cardiovascular events (CVE). Over the past decade, increased BP variability is an independent predictor for a higher risk of CVE. Among the major groups of antihypertensive drugs, there are calcium antagonists, mainly amlodipine, which has the greatest potential to reduce BP variability. Thus, calcium antagonists can be considered as first-line drugs for patients with high BP variability.

Keywords:

hypertension

hypertensive crisis

hypertensive urgency

blood pressure variability

calcium antagonists

Close metadata

References:

ESH/ESC Task Force for the Management of Arterial Hypertension. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2013;31(10):1925-1938. doi:10.1097/HJH.0b013e328364ca4c
Cherney D, Straus S. Management of patients with hypertensive urgencies and emergencies: a systematic review of the literature. J Gen Intern Med. 2002;17:937.
Grassi D, O'Flaherty M, Pellizzari M, Bendersky M, Rodriguez P, Turri D, Forcada P, Ferdinand KC, Kotliar C; Group of Investigators of the REHASE Program. Hypertensive urgencies in the emergency department: evaluating blood pressure response to rest and to antihypertensive drugs with different profiles. J Clin Hypertens (Greenwich). 2008;10:662. doi:10.1111/j.1751-7176.2008.00001.x
Diagnostics and treatment of arterial hypertension (Clinical Guidelines). Kardiologicheskij Vestnik. 2015;10(1):5-30. (In Russ.)
Perez MI, Musini VM. Pharmacological interventions for hypertensive emergencies: a Cochrane systematic review. J Hum Hypertens. 2008;22(9):596-607. doi:10.1038/jhh.2008.25
Varon J, Elliott WJ. Management of severe asymptomatic hypertension (hypertensive urgencies) in adults. Nov 29, 2016. Accessed December 27, 2016. http://www.uptodate.com/contents/management-of-severe-asymptomatic-hypertension-hypertensive-urgencies-in-adults
Tereshchenko S.N. Gipertonicheskie krizy: diagnostika i lechenie // Chazov E.I., Chazova I.E. Rukovodstvo po arterial'noi gipertonii. M.; 2005:676-689.
Tereshchenko S.N., Plavunov N.F. Gipertonicheskie krizy. M.: MEDprecs-inform; 2013.
Salinaro F, Gabba M, Mussinelli R. Hypertensive crises treatment in the real-world: are anti-anxiety drugs effective anti-hypertensive agents? European Heart Journal. 2016;37(Suppl.):1228-1229.
Nedostup AV, Fedorova VI, Dmitriev KV. Labile hypertension in elderly: clinical features, autonomic regulation of circulation, approaches to treatment. Klin Med (Mosk). 2000;78(7):27-32. (In Russ.)
Lavan AH, Gallagher P. Predicting risk of adverse drug reactions in older adults. Ther Adv Drug Saf. 2016;7(1):11-22. doi:10.1177/2042098615615472
Burton TJ, Wilkinson IB. The dangers of immediate-release nifedipine in the emergency treatment of hypertension. J Hum Hypertens. 2008;22(4):301-302. doi:10.1038/sj.jhh.1002324
Hata Y, Kimura Y, Muratani H, Fukiyama K, Kawano Y, Ashida T, Yokouchi M, Imai Y, Ozawa T, Fujii J, Omae T. Office blood pressure variability as a predictor of brain infarction in elderly hypertensive patients. Hypertens Res. 2000;23:553-560.
Hata Y, Muratani H, Kimura Y, Fukiyama K, Kawano Y, Ashida T, Yokouchi M, Imai Y, Ozawa T, Fujii J, Omae T. Office blood pressure variability as a predictor of acute myocardial infarction in elderly patients receiving antihypertensive therapy. J Hum Hypertens. 2002;16:141-146.
Parati G, Liu X, Ochoa JE, Bilo G. Prognostic relevance of blood pressure variability: role of long-term and very long-term blood pressure changes. Hypertension. 2013;62(4):682-684. doi:10.1161/HYPERTENSIONAHA.113.01801
Rothwell PM, Howard SC, Dolan E, O'Brien E, Dobson JE, Dahlцf B, Sever PS, Poulter NR. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 2010;375(9718):895-905. doi:10.1016/S0140-6736(10)60308-X
Johansson JK, Niiranen TJ, Puukka PJ, Jula AM. Prognostic value of the variability in home-measured blood pressure and heart rate: the Finn-Home Study. Hypertension. 2012;59(2):212-218. doi:10.1161/HYPERTENSIONAHA.111.178657
Kikuya M, Ohkubo T, Metoki H, Asayama K, Hara A, Obara T, Inoue R, Hoshi H, Hashimoto J, Totsune K, Satoh H, Imai Y. Day-by-day variability of blood pressure and heart rate at home as a novel predictor of prognosis: the Ohasama study. Hypertension. 2008;52(6):1045-1050. doi:10.1161/HYPERTENSIONAHA.107.104620
Webb AJ, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet. 2010;375(9718):906-915. doi:10.1016/S0140-6736(10)60235-8
Zhang Y, Agnoletti D, Safar ME, Blacher J. Effect of antihypertensive agents on blood pressure variability: the Natrilix SR versus candesartan and amlodipine in the reduction of systolic blood pressure in hypertensive patients (X-CELLENT) study. Hypertension. 2011;58(2):155-160. doi:10.1161/HYPERTENSIONAHA.111.174383
Wang JG, Yan P, Jeffers BW. Effects of amlodipine and other classes of antihypertensive drugs on long-term blood pressure variability: evidence from randomized controlled trials. J Am Soc Hypertens. 2014;8(5):340-349. doi:10.1016/j.jash.2014.02.004
Salles GF, Reboldi G, Fagard RH, Cardoso CR, Pierdomenico SD, Verdecchia P, Eguchi K, Kario K, Hoshide S, Polonia J, de la Sierra A, Hermida RC, Dolan E, O'Brien E, Roush GC; ABC-H Investigators. Prognostic Effect of the Nocturnal Blood Pressure Fall in Hypertensive Patients: The Ambulatory Blood Pressure Collaboration in Patients With Hypertension (ABC-H) Meta-Analysis. Hypertension. 2016;67(4):693-700. doi:10.1161/HYPERTENSIONAHA.115.06981